Aristotle Atlantic Partners, LLC Biomarin Pharmaceutical Inc Transaction History

Aristotle Atlantic Partners, LLC

$3.19 Billion
Q3 2024

A detailed history of Aristotle Atlantic Partners, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Aristotle Atlantic Partners, LLC holds 4,032 shares of BMRN stock, worth $271,676. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,032

Previous 33,310 87.9%

Holding current value

$271,676

Previous $2.74 Million 89.68%

% of portfolio

0.01%

Previous 0.09%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$69.02 - $93.84 $2.02 Million - $2.75 Million	-29,278 Reduced 87.9%	4,032 $283,000
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $56,566 - $70,087	-760 Reduced 2.23%	33,310 $2.74 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $105,600 - $124,740	-1,260 Reduced 3.57%	34,070 $2.98 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $39,710 - $51,323	521 Added 1.5%	35,330 $3.41 Million
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $1.01 Million - $1.12 Million	11,837 Added 51.53%	34,809 $3.08 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $1.52 Million - $1.75 Million	17,491 Added 319.12%	22,972 $1.99 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $480,902 - $642,756	5,481 New	5,481 $532,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $1.87 Million - $2.14 Million	-25,000 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$80.14 - $106.07 $16,028 - $21,214	-200 Reduced 0.79%	25,000 $2.13 Million
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $547,272 - $713,016	-7,200 Reduced 22.22%	25,200 $2.37 Million
Q1 2018 Sep 10, 2018	BUY	$77.67 - $92.63 $2.52 Million - $3 Million	32,400 New	32,400 $2.63 Million
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $2.52 Million - $3 Million	-32,400 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $2.62 Million - $3.08 Million	32,400	32,400 $2.89 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.

Account

Aristotle Atlantic Partners, LLC Biomarin Pharmaceutical Inc Transaction History